Related Experiment Videos
Isosorbide dinitrate and nifedipine in variant angina pectoris
American Heart Journal
|July 1, 1985
Summary
Combining isosorbide dinitrate (ISDN) with calcium antagonists effectively treats variant angina. This combination therapy improves coronary blood flow and patient outcomes, offering a rational approach to managing vasospastic angina.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Variant angina is characterized by coronary vasospasm.
- Isosorbide dinitrate (ISDN) is a nitrate used for angina management.
- Calcium antagonists are another class of drugs used for cardiovascular conditions.
Purpose of the Study:
- To evaluate the efficacy of combining ISDN with a calcium antagonist for variant angina.
- To compare the effects of ISDN and nifedipine in patients with variant angina.
Main Methods:
- A prospective, double-blind, crossover trial involving 19 patients with variant angina.
- Patients received varying doses of ISDN and nifedipine.
- Quantitative angiography was used to assess vasodilator potency.
Main Results:
- Both ISDN and nifedipine were effective in controlling vasospastic angina.
- Individual patient responses varied between the two drugs.
- Intracoronary nitroglycerin demonstrated greater vasodilator potency than sublingual nifedipine.
Conclusions:
- Combination therapy with ISDN and calcium antagonists is a rational and effective treatment for variant angina.
- This combination enhances coronary blood flow and improves long-term prognosis.
- The synergistic action of nitrates and calcium antagonists may prevent coronary vasospasm.